adverse eventUncategorizedsafetyefficacysonidegibsonic hedgehogbasal cell carcinomatreatmentclinical trialEfficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial
Homepage Featured SliderThe Gorlin Syndrome Alliance and NORD Launch Natural History Study for Gorlin Syndrome
dermatologyScience ArticlesAssessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis
Science ArticlesTreatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting
dermatologyScience ArticlesKey Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis
General Informationclinical presentationpediatricsdiagnosisgeneticsScience ArticlesProposed criteria for nevoid basal cell carcinoma syndrome in children assessed using statistical optimization
Clinical Trial UpdatesCODY Trial: Clinical Trial of a topical gel for the prevention of basal cell carcinomas in adults with Gorlin syndrome.
dermatologyScience ArticlesFive-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma
Gorlin Syndromebasal carcinoma nevus syndromepalmar pitscase reportclinical presentationgorlin golzD2-40utaneous keratocystsBCCdermatologyScience ArticlesbccnsCutaneous Keratocyst With D2-40 Immunoreactivity in Basal Cell Nevus Syndrome